Drugs / Mg Pidolate
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00040456 Comparator | Jan 2001 → May 2006 | sickle cell-hemoglobin c disease syndrome | Baylor College of Medicine | Terminated | No outcome recorded Stop: Enrollment |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mg Pidolate | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00040456 ↗ |
| Known as | Magnesium Pidolate | “Magnesium Pidolate” NCT00040456 ↗ |
| Route | Oral | “Oral Magnesium Pidolate” NCT00040456 ↗ |